nach oben

Journal of Endocrinological Investigation

Erschienen in:

14.11.2023 | Review

Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis

verfasst von: F. Folli, L. Centofanti, S. Magnani, E. Tagliabue, M. Bignotto, L. La Sala, A. E. Pontiroli

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

The role of overweight and obesity in the development of atrial fibrillation (AF) is well established; however, the differential effect on the occurrence and recurrence of AF remains uncertain. The aim of this review is to compare the effect of underweight and varying degrees of obesity on onset of AF and in recurrent post-ablation AF, and, when possible, in relation to sex.

Methods

A systematic literature search was conducted in PubMed, Embase, and Cochrane Library from inception to January 31, 2023. Studies reporting frequency of newly-diagnosed AF and of recurrent post-ablation AF in different BMI categories, were included. 3400 records were screened and 50 met the inclusion criteria. Standardized data search and abstraction were performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement. Data were extracted from the manuscripts and were analyzed using a random effect model. The outcome was the occurrence of AF in population studies and in patients undergoing ablation.

Results

Data from 50 studies were collected, of which 27 for newly-diagnosed AF and 23 for recurrent post-ablation AF, for a total of 15,134,939 patients, of which 15,115,181 in studies on newly-diagnosed AF and 19,758 in studies on recurrent post-ablation AF. Compared to normal weight, the increase in AF was significant (p < 0.01) for overweight, obese, and morbidly obese patients for newly-diagnosed AF, and for obese and morbidly obese patients for recurrent post-ablation AF. Newly-diagnosed AF was more frequent in obese female than obese male patients.

Conclusion

The effect of increased BMI was greater on the onset of AF, and obese women were more affected than men.

Nur mit Berechtigung zugänglich

Morin DP, Bernard ML, Madias C, Rogers PA, Thihalolipavan S, Estes NAM (2016) The state of the art: atrial fibrillation epidemiology, prevention, and treatment. Mayo Clin Proc 91:1778–1810. https://doi.org/10.1016/j.mayocp.2016.08.022CrossRefPubMed

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan G-A, Dilaveris PE et al (2021) 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the Special Contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42:373–498. https://doi.org/10.1093/eurheartj/ehaa612CrossRefPubMed

Erhard N, Metzner A, Fink T (2022) Late arrhythmia recurrence after atrial fibrillation ablation: incidence mechanisms and clinical implications. Herzschrittmachertherapie Elektrophysiol 33:71–76. https://doi.org/10.1007/s00399-021-00836-6CrossRef

Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS (2008) Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 155:310–315. https://doi.org/10.1016/j.ahj.2007.10.004CrossRefPubMed

Aune D, Sen A, Schlesinger S, Norat T, Janszky I, Romundstad P, Tonstad S, Riboli E, Vatten LJ (2017) Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol 32:181–192. https://doi.org/10.1007/s10654-017-0232-4CrossRefPubMedPubMedCentral

Asad Z, Abbas M, Javed I, Korantzopoulos P, Stavrakis S (2018) Obesity is associated with incident atrial fibrillation independent of gender: a meta-analysis. J Cardiovasc Electrophysiol 29:725–732. https://doi.org/10.1111/jce.13458CrossRefPubMed

Wong CX, Sullivan T, Sun MT, Mahajan R, Pathak RK, Middeldorp M, Twomey D, Ganesan AN, Rangnekar G, Roberts-Thomson KC et al (2015) Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol 1:139–152. https://doi.org/10.1016/j.jacep.2015.04.004CrossRefPubMed

Guijian L, Jinchuan Y, Rongzeng D, Jun Q, Jun W, Wenqing Z (2013) Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies. Pacing Clin Electrophysiol PACE 36:748–756. https://doi.org/10.1111/pace.12106CrossRefPubMed

Pranata R, Henrina J, Yonas E, Putra ICS, Cahyadi I, Lim MA, Munawar DA, Munawar M (2021) BMI and atrial fibrillation recurrence post catheter ablation: a dose-response meta-analysis. Eur J Clin Investig 51:e13499. https://doi.org/10.1111/eci.13499CrossRef

10.

Liu F, Song T, Hu Q, Zhu X, Zhao H, Tan Z, Yu P, Ma J, Luo J, Liu X (2022) Body mass index and atrial fibrillation recurrence post ablation: a systematic review and dose-response meta-analysis. Front Cardiovasc Med 9:999845. https://doi.org/10.3389/fcvm.2022.999845CrossRefPubMed

11.

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) PRISMA Group preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med Peer Rev Indep Open Access J 3:e123-130

12.

Wilhelmsen L, Rosengren A, Lappas G (2001) Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med 250:382–389. https://doi.org/10.1046/j.1365-2796.2001.00902.xCrossRefPubMed

13.

Wang TJ, Parise H, Levy D, D’Agostino RB, Wolf PA, Vasan RS, Benjamin EJ (2004) Obesity and the risk of new-onset atrial fibrillation. JAMA 292:2471–2477. https://doi.org/10.1001/jama.292.20.2471CrossRefPubMed

14.

Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJV (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15,000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 27:96–106. https://doi.org/10.1093/eurheartj/ehi506CrossRefPubMed

15.

Rosengren A, Hauptman PJ, Lappas G, Olsson L, Wilhelmsen L, Swedberg K (2009) Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 30:1113–1120. https://doi.org/10.1093/eurheartj/ehp076CrossRefPubMed

16.

Zhang X, Zhang S, Li Y, Detrano RC, Chen K, Li X, Zhao L, Benjamin EJ, Wu Y (2005) Association of obesity and atrial fibrillation among middle-aged and elderly Chinese. Int J Obes 2009(33):1318–1325. https://doi.org/10.1038/ijo.2009.157CrossRef

17.

Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE, Buring JE, Albert CM (2010) The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (Women’s Health Study). J Am Coll Cardiol 55:2319–2327. https://doi.org/10.1016/j.jacc.2010.02.029CrossRefPubMedPubMedCentral

18.

Grundvold I, Skretteberg PT, Liestøl K, Gjesdal K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2012) Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men. Am J Cardiol 110:425–432. https://doi.org/10.1016/j.amjcard.2012.03.043CrossRefPubMed

19.

Karasoy D, Bo Jensen T, Hansen ML, Schmiegelow M, Lamberts M, Gislason GH, Hansen J, Torp-Pedersen C, Olesen JB (2013) Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 15:781–786. https://doi.org/10.1093/europace/eus422CrossRef

20.

Azarbal F, Stefanick ML, Salmoirago-Blotcher E, Manson JE, Albert CM, LaMonte MJ, Larson JC, Li W, Martin LW, Nassir R et al (2014) Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. J Am Heart Assoc 3:e001127. https://doi.org/10.1161/JAHA.114.001127CrossRefPubMedPubMedCentral

21.

Frost L, Benjamin EJ, Fenger-Grøn M, Pedersen A, Tjønneland A, Overvad K (2014) Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish Cohort Study. Obes Silver Spring Md 22:1546–1552. https://doi.org/10.1002/oby.20706CrossRef

22.

Huxley RR, Misialek JR, Agarwal SK, Loehr LR, Soliman EZ, Chen LY, Alonso A (2014) Physical activity, obesity, weight change, and risk of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol 7:620–625. https://doi.org/10.1161/CIRCEP.113.001244CrossRefPubMedPubMedCentral

23.

Schmidt M, Bøtker HE, Pedersen L, Sørensen HT (2014) Comparison of the frequency of atrial fibrillation in young obese versus young nonobese men undergoing examination for fitness for military service. Am J Cardiol 113:822–826. https://doi.org/10.1016/j.amjcard.2013.11.037CrossRefPubMed

24.

Berkovitch A, Kivity S, Klempfner R, Segev S, Milwidsky A, Erez A, Sabbag A, Goldenberg I, Sidi Y, Maor E (2016) Body mass index and the risk of new-onset atrial fibrillation in middle-aged adults. Am Heart J 173:41–48. https://doi.org/10.1016/j.ahj.2015.11.016CrossRefPubMed

25.

Grundvold I, Bodegard J, Nilsson PM, Svennblad B, Johansson G, Östgren CJ, Sundström J (2015) Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study. Cardiovasc Diabetol 14:5. https://doi.org/10.1186/s12933-014-0170-3CrossRefPubMedPubMedCentral

26.

Kokubo Y, Watanabe M, Higashiyama A, Nakao YM, Kobayashi T, Watanabe T, Okamura T, Okayama A, Miyamoto Y (2015) Interaction of blood pressure and body mass index with risk of incident atrial fibrillation in a japanese urban cohort: the suita study. Am J Hypertens 28:1355–1361. https://doi.org/10.1093/ajh/hpv038CrossRefPubMed

27.

Nyström PK, Carlsson AC, Leander K, de Faire U, Hellenius M-L, Gigante B (2015) Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, Prospective Cohort Study. PLoS One 10:e0127111. https://doi.org/10.1371/journal.pone.0127111CrossRefPubMedPubMedCentral

28.

Diouf I, Magliano DJ, Carrington MJ, Stewart S, Shaw JE (2016) Prevalence, incidence, risk factors and treatment of atrial fibrillation in Australia: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Longitudinal, Population Cohort Study. Int J Cardiol 205:127–132. https://doi.org/10.1016/j.ijcard.2015.12.013CrossRefPubMed

29.

Baek Y-S, Yang P-S, Kim T-H, Uhm J-S, Park J, Pak H-N, Lee M-H, Joung B (2017) Associations of abdominal obesity and new-onset atrial fibrillation in the general population. J Am Heart Assoc 6:e004705. https://doi.org/10.1161/JAHA.116.004705CrossRefPubMedPubMedCentral

30.

Persson CE, Adiels M, Björck L, Rosengren A (2018) Young women, body size and risk of atrial fibrillation. Eur J Prev Cardiol 25:173–180. https://doi.org/10.1177/2047487317740644CrossRefPubMed

31.

Feng T, Vegard M, Strand LB, Laugsand LE, Mørkedal B, Aune D, Vatten L, Ellekjaer H, Loennechen JP, Mukamal K et al (2019) Metabolically healthy obesity and risk for atrial fibrillation: the HUNT Study. Obes Silver Spring Md 27:332–338. https://doi.org/10.1002/oby.22377CrossRef

32.

Kim YG, Han K-D, Choi J-I, Boo KY, Kim DY, Oh S-K, Lee K-N, Shim J, Kim JS, Kim Y-H (2019) The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study. Cardiovasc Diabetol 18:128. https://doi.org/10.1186/s12933-019-0932-zCrossRefPubMedPubMedCentral

33.

Neefs J, Boekholdt SM, Khaw K-T, Luben R, Pfister R, Wareham NJ, Meulendijks ER, Sanders P, de Groot JR (2019) Body mass index and body fat distribution and new-onset atrial fibrillation: substudy of the European Prospective Investigation into Cancer and Nutrition in Norfolk (EPIC-Norfolk) Study. Nutr Metab Cardiovasc Dis NMCD 29:692–700. https://doi.org/10.1016/j.numecd.2019.03.005CrossRefPubMed

34.

Kamil-Rosenberg S, Kokkinos P, Grune de Souza E, Silva C, Yee WLS, Abella J, Chan K, Myers J (2020) Association between cardiorespiratory fitness, obesity, and incidence of atrial fibrillation. Int J Cardiol Heart Vasc 31:100663. https://doi.org/10.1016/j.ijcha.2020.100663CrossRefPubMedPubMedCentral

35.

Singleton MJ, German CA, Soliman EZ, Whalen SP, Bhave PD, Bertoni AG, Yeboah J (2020) Body mass index, sex, and incident atrial fibrillation in diabetes: the ACCORD trial. JACC Clin Electrophysiol 6:1713–1720. https://doi.org/10.1016/j.jacep.2020.08.008CrossRefPubMed

36.

Poorthuis MHF, Sherliker P, de Borst GJ, Carter JL, Lam KBH, Jones NR, Halliday A, Lewington S, Bulbulia R (2021) Joint associations between body mass index and waist circumference with atrial fibrillation in men and women. J Am Heart Assoc 10:e019025. https://doi.org/10.1161/JAHA.120.019025CrossRefPubMedPubMedCentral

37.

Zia I, Johnson L, Memarian E, Borné Y, Engström G (2021) Anthropometric measures and the risk of developing atrial fibrillation: a Swedish cohort study. BMC Cardiovasc Disord 21:602. https://doi.org/10.1186/s12872-021-02415-6CrossRefPubMedPubMedCentral

38.

Djekic D, Lindgren M, Åberg ND, Åberg M, Fengsrud E, Poci D, Adiels M, Rosengren A (2022) Body mass index in adolescence and long-term risk of early incident atrial fibrillation and subsequent mortality, heart failure, and ischemic stroke. J Am Heart Assoc 11:e025984. https://doi.org/10.1161/JAHA.121.025984CrossRefPubMedPubMedCentral

39.

Cha Y-M, Friedman PA, Asirvatham SJ, Shen W-K, Munger TM, Rea RF, Brady PA, Jahangir A, Monahan KH, Hodge DO et al (2008) Catheter ablation for atrial fibrillation in patients with obesity. Circulation 117:2583–2590. https://doi.org/10.1161/CIRCULATIONAHA.107.716712CrossRefPubMed

40.

Lakkireddy DR, Blake GE, Patel D, Rotter M, Verma A, Ryschon K, Khan M, Schweikert R, Haissaguerre M, Natale A (2008) Success of radiofrequency catheter ablation of atrial fibrillation: does obesity influence the outcomes? J Atr Fibrillation 1:36. https://doi.org/10.4022/jafib.36CrossRefPubMedPubMedCentral

41.

Tang R-B, Dong J-Z, Liu X-P, Kang J-P, Ding S-F, Wang L, Long D-Y, Yu R-H, Liu X-H, Liu S et al (2009) Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 11:100–105. https://doi.org/10.1093/europace/eun315CrossRef

42.

Chilukuri K, Dalal D, Gadrey S, Marine JE, Macpherson E, Henrikson CA, Cheng A, Nazarian S, Sinha S, Spragg D et al (2010) A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 21:521–525. https://doi.org/10.1111/j.1540-8167.2009.01653.xCrossRefPubMed

43.

Letsas KP, Siklódy CH, Korantzopoulos P, Weber R, Bürkle G, Mihas CC, Kalusche D, Arentz T (2013) The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation. Int J Cardiol 164:94–98. https://doi.org/10.1016/j.ijcard.2011.06.092CrossRefPubMed

44.

Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Jacobs V, Mallender C, Muhlestein JB, Osborn JS, Weiss JP et al (2016) Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation. J Interv Card Electrophysiol Int J Arrhythm Pacing 46:259–265. https://doi.org/10.1007/s10840-016-0142-5CrossRef

45.

Winkle RA, Mead RH, Engel G, Kong MH, Fleming W, Salcedo J, Patrawala RA (2017) Impact of obesity on atrial fibrillation ablation: patient characteristics, long-term outcomes, and complications. Heart Rhythm 14:819–827. https://doi.org/10.1016/j.hrthm.2017.02.023CrossRefPubMed

46.

Deng H, Shantsila A, Guo P, Potpara TS, Zhan X, Fang X, Liao H, Liu Y, Wei W, Fu L et al (2018) A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: a report from the Guangzhou atrial fibrillation ablation registry. EBioMedicine 35:40–45. https://doi.org/10.1016/j.ebiom.2018.08.034CrossRefPubMedPubMedCentral

47.

Mohanty S, Mohanty P, Natale V, Trivedi C, Gianni C, Burkhardt JD, Sanchez JE, Horton R, Gallinghouse GJ, Hongo R et al (2018) Impact of weight loss on ablation outcome in obese patients with longstanding persistent atrial fibrillation. J Cardiovasc Electrophysiol 29:246–253. https://doi.org/10.1111/jce.13394CrossRefPubMed

48.

Sivasambu B, Balouch MA, Zghaib T, Bajwa RJ, Chrispin J, Berger RD, Ashikaga H, Nazarian S, Marine JE, Calkins H et al (2018) Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients. J Cardiovasc Electrophysiol 29:239–245. https://doi.org/10.1111/jce.13388CrossRefPubMed

49.

Donnellan E, Wazni OM, Kanj M, Baranowski B, Cremer P, Harb S, McCarthy CP, McEvoy JW, Elshazly MB, Aagaard P et al (2019) Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 21:1476–1483. https://doi.org/10.1093/europace/euz183CrossRef

50.

Glover BM, Hong KL, Dagres N, Arbelo E, Laroche C, Riahi S, Bertini M, Mikhaylov EN, Galvin J, Kiliszek M et al (2019) Impact of body mass index on the outcome of catheter ablation of atrial fibrillation. Heart Br Card Soc 105:244–250. https://doi.org/10.1136/heartjnl-2018-313490CrossRef

51.

Providência R, Adragão P, de Asmundis C, Chun J, Chierchia G, Defaye P, Anselme F, Creta A, Lambiase PD, Schmidt B et al (2019) Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European observational multicenter study. J Am Heart Assoc 8:e012253. https://doi.org/10.1161/JAHA.119.012253CrossRefPubMedPubMedCentral

52.

Donnellan E, Wazni OM, Kanj M, Elshazly M, Hussein AA, Patel DR, Trulock K, Wilner B, Baranowski B, Cantillon DJ et al (2020) Impact of risk-factor modification on arrhythmia recurrence among morbidly obese patients undergoing atrial fibrillation ablation. J Cardiovasc Electrophysiol 31:1979–1986. https://doi.org/10.1111/jce.14607CrossRefPubMed

53.

Weinmann K, Bothner C, Rattka M, Aktolga D, Teumer Y, Rottbauer W, Dahme T, Pott A (2020) Pulmonary vein isolation with the cryoballoon in obese atrial fibrillation patients—does weight have an impact on procedural parameters and clinical outcome? Int J Cardiol 316:137–142. https://doi.org/10.1016/j.ijcard.2020.06.001CrossRefPubMed

54.

Yaeger A, Keenan BT, Cash NR, Parham T, Deo R, Frankel DS, Schaller RD, Santangeli P, Nazarian S, Supple GE et al (2020) Impact of a nurse-led limited risk factor modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation. J Cardiovasc Electrophysiol 31:423–431. https://doi.org/10.1111/jce.14336CrossRefPubMed

55.

YewDing W, Kozhuharov N, Hao Chin S, Shaw M, Snowdon R, Lip GYH, Gupta D (2020) Feasibility of weight loss in obese atrial fibrillation patients attending a specialist arrhythmia clinic and its impact on ablation outcomes. J Arrhythmia 36:984–990. https://doi.org/10.1002/joa3.12432CrossRef

56.

Blockhaus C, Waibler H-P, Gülker J-E, Bufe A, Seyfarth M, Koektuerk B, Shin D-I (2021) Influence of excess weight and obesity on performance and outcome of pulmonary vein isolation with the cryoballoon. Rev Cardiovasc Med 22:1047–1052. https://doi.org/10.31083/j.rcm2203114CrossRefPubMed

57.

Gessler N, Willems S, Steven D, Aberle J, Akbulak RO, Gosau N, Hoffmann BA, Meyer C, Sultan A, Tilz R et al (2021) Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 23:1548–1558. https://doi.org/10.1093/europace/euab122CrossRef

58.

MacGregor RM, Khiabani AJ, Bakir NH, Kelly MO, Perez SC, Maniar HS, Schuessler RB, Moon MR, Melby SJ, Damiano RJ (2021) Impact of obesity on atrial fibrillation recurrence following stand-alone cox maze IV procedure. Innov Phila Pa 16:434–440. https://doi.org/10.1177/15569845211017176CrossRef

59.

Malaspina D, Brasca F, Iacopino S, Arena G, Molon G, Pieragnoli P, Tondo C, Manfrin M, Rovaris G, Verlato R et al (2021) Cryoablation for pulmonary veins isolation in obese patients with atrial fibrillation compared to nonobese patients. Pacing Clin Electrophysiol PACE 44:306–317. https://doi.org/10.1111/pace.14149CrossRefPubMed

60.

Peigh G, Wasserlauf J, Vogel K, Kaplan RM, Pfenniger A, Marks D, Mehta A, Chicos AB, Arora R, Kim S et al (2021) Impact of pre-ablation weight loss on the success of catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol 32:2097–2104. https://doi.org/10.1111/jce.15141CrossRefPubMedPubMedCentral

61.

Urbanek L, Bordignon S, Chen S, Bologna F, Tohoku S, Dincher M, Schulte-Hahn B, Schmidt B, Chun K-RJ (2022) Impact of body mass index on cryoablation of atrial fibrillation: patient characteristics, procedural data, and long-term outcomes. J Cardiovasc Electrophysiol 33:1106–1115. https://doi.org/10.1111/jce.15478CrossRefPubMed

62.

Wells GA, Shea B, Higgins JP, Sterne J, Tugwell P, Reeves BC (2013) Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews. Res Synth Methods 4:63–77. https://doi.org/10.1002/jrsm.1077CrossRefPubMed

63.

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2CrossRefPubMed

64.

Hartung J, Knapp G (2001) A refined method for the meta-analysis of controlled clinical trials with binary outcome. Stat Med 20:3875–3889. https://doi.org/10.1002/sim.1009CrossRefPubMed

65.

Higgins JPT, Thompson SG, Spiegelhalter DJ (2009) A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 172:137–159. https://doi.org/10.1111/j.1467-985X.2008.00552.xCrossRefPubMedPubMedCentral

66.

Kim SY, Park JE, Lee YJ, Seo H-J, Sheen S-S, Hahn S, Jang B-H, Son H-J (2013) Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 66:408–414. https://doi.org/10.1016/j.jclinepi.2012.09.016CrossRefPubMed

67.

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple. Graph Test BMJ 315:629–634. https://doi.org/10.1136/bmj.315.7109.629CrossRef

68.

Linde C, Bongiorni MG, Birgersdotter-Green U, Curtis AB, Deisenhofer I, Furokawa T, Gillis AM, Haugaa KH, Lip GYH, Van Gelder I et al (2018) Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 20:1565ao. https://doi.org/10.1093/europace/euy067CrossRef

69.

Lip GYH, Laroche C, Boriani G, Cimaglia P, Dan G-A, Santini M, Kalarus Z, Rasmussen LH, Popescu MI, Tica O et al (2015) Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro observational research Programme Pilot Survey on atrial fibrillation. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 17:24–31. https://doi.org/10.1093/europace/euu155CrossRef

70.

Potpara TS, Marinkovic JM, Polovina MM, Stankovic GR, Seferovic PM, Ostojic MC, Lip GYH (2012) Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. Int J Cardiol 161:39–44. https://doi.org/10.1016/j.ijcard.2011.04.022CrossRefPubMed

71.

Piccini JP, Simon DN, Steinberg BA, Thomas L, Allen LA, Fonarow GC, Gersh B, Hylek E, Kowey PR, Reiffel JA et al (2016) Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF Registry. JAMA Cardiol 1:282–291. https://doi.org/10.1001/jamacardio.2016.0529CrossRefPubMed

72.

Boriani G, Laroche C, Diemberger I, Fantecchi E, Meeder J, Kurpesa M, Baluta MM, Proietti M, Tavazzi L, Maggioni AP et al (2018) Overweight and obesity in patients with atrial fibrillation: sex differences in 1-year outcomes in the EORP-AF General Pilot Registry. J Cardiovasc Electrophysiol 29:566–572. https://doi.org/10.1111/jce.13428CrossRefPubMed

73.

Costa S, Saguner AM, Gasperetti A, Akdis D, Brunckhorst C, Duru F (2021) The link between sex hormones and susceptibility to cardiac arrhythmias: from molecular basis to clinical implications. Front Cardiovasc Med 8:644279. https://doi.org/10.3389/fcvm.2021.644279CrossRefPubMedPubMedCentral

74.

Camm CF, Lacey B, Massa MS, Von Ende A, Gajendragadkar P, Stiby A, Valdes-Marquez E, Lewington S, Wijesurendra R, Parish S et al (2022) Independent effects of adiposity measures on risk of atrial fibrillation in men and women: a study of 0.5 million individuals. Int J Epidemiol 51:984–995. https://doi.org/10.1093/ije/dyab184CrossRefPubMed

75.

Palmer BF, Clegg DJ (2015) The sexual dimorphism of obesity. Mol Cell Endocrinol 402:113–119. https://doi.org/10.1016/j.mce.2014.11.029CrossRefPubMed

76.

López-Canoa JN, Couselo-Seijas M, Baluja A, González-Melchor L, Rozados A, Llorente-Cortés V, de Gonzalo-Calvo D, Guerra JM, Vilades D, Leta R et al (2021) Sex-Related differences of fatty acid-binding protein 4 and leptin levels in atrial fibrillation. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 23:682–690. https://doi.org/10.1093/europace/euaa284CrossRef

77.

Perego L, Pizzocri P, Corradi D, Maisano F, Paganelli M, Fiorina P, Barbieri M, Morabito A, Paolisso G, Folli F et al (2005) Circulating leptin correlates with left ventricular mass in morbid (Grade III) Obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J Clin Endocrinol Metab 90:4087–4093. https://doi.org/10.1210/jc.2004-1963CrossRefPubMed

78.

Rabkin SW (2014) The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord 12:31–42. https://doi.org/10.1089/met.2013.0107CrossRefPubMed

79.

Iacobellis G (2022) Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol 19:593–606. https://doi.org/10.1038/s41569-022-00679-9CrossRefPubMedPubMedCentral

80.

Gauci S, Cartledge S, Redfern J, Gallagher R, Huxley R, Lee CMY, Vassallo A, O’Neil A (2022) Biology, bias, or both? The contribution of sex and gender to the disparity in cardiovascular outcomes between women and men. Curr Atheroscler Rep 24:701–708. https://doi.org/10.1007/s11883-022-01046-2CrossRefPubMedPubMedCentral

81.

Magnani S, Muser D, Chik W, Santangeli P (2015) Adjunct ablation strategies for persistent atrial fibrillation-beyond pulmonary vein isolation. J Thorac Dis 7:178–184. https://doi.org/10.3978/j.issn.2072-1439.2015.01.25CrossRefPubMedPubMedCentral

82.

Karatela MF, Fudim M, Mathew JP, Piccini JP (2023) Neuromodulation therapy for atrial fibrillation. Heart Rhythm 20:100–111. https://doi.org/10.1016/j.hrthm.2022.08.011CrossRefPubMed

83.

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H-C, Heidbuchel H, Hendriks J et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardio Thorac Surg Off J Eur Assoc Cardio-Thorac Surg 50:e1–e88. https://doi.org/10.1093/ejcts/ezw313CrossRef

84.

Kachur S, Lavie CJ, de Schutter A, Milani RV, Ventura HO (2017) Obesity and cardiovascular diseases. Minerva Med 108:212–228. https://doi.org/10.23736/S0026-4806.17.05022-4CrossRefPubMed

85.

Willar B, Tran K-V, Fitzgibbons TP (2023) Epicardial adipocytes in the pathogenesis of atrial fibrillation: an update on basic and translational studies. Front Endocrinol 14:1154824. https://doi.org/10.3389/fendo.2023.1154824CrossRef

86.

Kato T, Iwasaki Y, Nattel S (2012) Connexins and atrial fibrillation: filling in the gaps. Circulation 125:203–206. https://doi.org/10.1161/CIRCULATIONAHA.111.075432CrossRefPubMed

87.

Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, Mahajan R, Kuklik P, Zhang Y, Brooks AG et al (2013) Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 10:90–100. https://doi.org/10.1016/j.hrthm.2012.08.043CrossRefPubMed

88.

Mahajan R, Lau DH, Brooks AG, Shipp NJ, Manavis J, Wood JPM, Finnie JW, Samuel CS, Royce SG, Twomey DJ et al (2015) Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol 66:1–11. https://doi.org/10.1016/j.jacc.2015.04.058CrossRefPubMed

89.

Packer M (2018) Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol 71:2360–2372. https://doi.org/10.1016/j.jacc.2018.03.509CrossRefPubMed

90.

Kita S, Maeda N, Shimomura I (2019) Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome. J Clin Investig 129:4041–4049. https://doi.org/10.1172/JCI129193CrossRefPubMedPubMedCentral

91.

La Sala L, Pontiroli AE (2020) Prevention of diabetes and cardiovascular disease in obesity. Int J Mol Sci 21:8178. https://doi.org/10.3390/ijms21218178CrossRefPubMedPubMedCentral

92.

Shaihov-Teper O, Ram E, Ballan N, Brzezinski RY, Naftali-Shani N, Masoud R, Ziv T, Lewis N, Schary Y, Levin-Kotler L-P et al (2021) Extracellular vesicles from epicardial fat facilitate atrial fibrillation. Circulation 143:2475–2493. https://doi.org/10.1161/CIRCULATIONAHA.120.052009CrossRefPubMed

93.

Chen J, Mei Z, Yang Y, Dai C, Wang Y, Zeng R, Liu Q (2022) Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis. BMC Cardiovasc Disord 22:264. https://doi.org/10.1186/s12872-022-02703-9CrossRefPubMedPubMedCentral

94.

Feraco A, Marzolla V, Scuteri A, Armani A, Caprio M (2020) Mineralocorticoid receptors in metabolic syndrome: from physiology to disease. Trends Endocrinol Metab TEM 31:205–217. https://doi.org/10.1016/j.tem.2019.11.006CrossRefPubMed

95.

Harada M, Nattel S (2021) Implications of inflammation and fibrosis in atrial fibrillation pathophysiology. Card Electrophysiol Clin 13:25–35. https://doi.org/10.1016/j.ccep.2020.11.002CrossRefPubMed

96.

Lavall D, Selzer C, Schuster P, Lenski M, Adam O, Schäfers H-J, Böhm M, Laufs U (2014) The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation. J Biol Chem 289:6656–6668. https://doi.org/10.1074/jbc.M113.519256CrossRefPubMedPubMedCentral

97.

Launbo N, Zobel EH, von Scholten BJ, Faerch K, Jørgensen PG, Christensen RH (2021) Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: a systematic review and meta-analysis. Obes Rev Off J Int Assoc Study Obes 22:e13136. https://doi.org/10.1111/obr.13136CrossRef

98.

Aga YS, Kroon D, Snelder SM, Biter LU, de Groot-de Laat LE, Zijlstra F, Brugts JJ, van Dalen BM (2023) Decreased left atrial function in obesity patients without known cardiovascular disease. Int J Cardiovasc Imaging 39:471–479. https://doi.org/10.1007/s10554-022-02744-3CrossRefPubMed

99.

Folli F, Pontiroli AE, Schwesinger WH (2007) Metabolic aspects of bariatric surgery. Med Clin N Am 91:393–414. https://doi.org/10.1016/j.mcna.2007.01.005CrossRefPubMed

100.

Deal O, Rayner J, Stracquadanio A, Wijesurendra RS, Neubauer S, Rider O, Spartera M (2022) Effect of weight loss on early left atrial myopathy in people with obesity but no established cardiovascular disease. J Am Heart Assoc 11:e026023. https://doi.org/10.1161/JAHA.122.026023CrossRefPubMedPubMedCentral

101.

Pontiroli AE, Centofanti L, Le Roux CW, Magnani S, Tagliabue E, Folli F (2023) Effect of prolonged and substantial weight loss on incident atrial fibrillation: a systematic review and meta-analysis. Nutrients 15:940. https://doi.org/10.3390/nu15040940CrossRefPubMedPubMedCentral

102.

Park DY, An S, Murthi M, Kattoor AJ, Kaur A, Ravi V, Huang HD, Vij A (2022) Effect of weight loss on recurrence of atrial fibrillation after ablative therapy: a systematic review and meta-analysis. J Interv Card Electrophysiol Int J Arrhythm Pacing 64:763–771. https://doi.org/10.1007/s10840-022-01168-2CrossRef

103.

Deng H, Bai Y, Shantsila A, Fauchier L, Potpara TS, Lip GYH (2017) Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review. Clin Res Cardiol Off J Ger Card Soc 106:813–823. https://doi.org/10.1007/s00392-017-1123-0CrossRef

Titel: Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis
verfasst von: F. Folli
L. Centofanti
S. Magnani
E. Tagliabue
M. Bignotto
L. La Sala
A. E. Pontiroli
Publikationsdatum: 14.11.2023
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 5/2024
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-023-02225-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis

Abstract

Background and aims

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background and aims

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2024

Novel alternative tools for metastatic pheochromocytomas/paragangliomas prediction

Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study

Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people

Clustering of gout-related comorbidities and their relationship with gout flares: a data-driven cluster analysis of eight comorbidities

Comment on: Semaglutide and cardiovascular outcomes in obesity without diabetes

Establishment of gestational diabetes risk prediction model and clinical verification

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin